Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1. 系统已在2025-04-18 11:28:43对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1002/cpt.3439
文献链接: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3439
其他信息:
出版社: Wiley
作者: Prathap Nagaraja Shastri; Nirav Shah; Martin Lechmann; Hardik Mody; Marc W. Retter; Min Zhu; Tommy Li; Jun Wang; Naveed Shaik; Xirong Zheng; Meric Ovacik; Fei Hua; Vibha Jawa; Christophe Boetsch; Yanguang Cao; John Burke; Kaushik Datta; Kapil Gadkar; Vijay Upreti; Alison Betts